Sacituzumab govitecan
Product Specifications
CAS Number
1491917-83-9
Target
Antibody-Drug Conjugates (ADCs) |||TROP2
Related Pathways
Immunology/Inflammation|||Antibody-drug Conjugate/ADC Related
Purity
0.984
Bioactivity
Sacituzumab govitecan (IMMU-132) is a humanized ADC compound targeting Trop-2 with anticancer activity for the study of refractory, locally advanced or metastatic breast cancer and uroepithelial cancer.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
I8700-05P-FITC 100 µL
IRS1, phosphorylated (Ser302 mouse/ Ser307 human) (Insulin receptor substrate 1, HIRS-1, Insulin receptor substrate 1, IRS-1) (FITC)
Ask
View Details 